Advertisement
Oaktree Acquisition Corp.... (OACC)
NASDAQ: OACC
· Real-Time Price · USD
10.45
0.05 (0.48%)
At close: Apr 29, 2025, 9:44 AM
Company Description
Oaktree Acquisition Corp.
III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences
| Country | United States |
| IPO Date | Dec 16, 2024 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Zaid Pardesi |
Advertisement
Contact Details
Address: 333 South Grand Avenue Los Angeles, California United States | |
| Website | https://www.oaktreeacquisitioncorp.com/oac-iii |
Stock Details
| Ticker Symbol | OACC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001845036 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Zaid Pardesi | Chief Executive Officer & Director |
| Courtney Conigliaro | Chief Financial Officer |
| Mathew M. Pendo | Chief Operation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | 10-K | Annual Report |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 18, 2024 | CORRESP | Filing |
| Oct 18, 2024 | UPLOAD | Filing |
| Oct 04, 2024 | CORRESP | Filing |
| Oct 01, 2024 | UPLOAD | Filing |
| Sep 13, 2024 | DRSLTR | Filing |
| Sep 13, 2024 | DRS/A | [Amend] Filing |
| Sep 05, 2024 | UPLOAD | Filing |